Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

Boosting protein intake helped semaglutide users to protect against some of this lean muscle loss, though. At month 3 of ...

SAN FRANCISCO -- In order to maximize weight loss, a GLP-1 receptor agonist may be needed both before and after bariatric ...

GLP-1 receptor agonists such as semaglutide and liraglutide promote significant weight loss and improved glycemic control, ...

Researchers have determined in a new study that the glucagon-like peptide-1 receptor agonists (GLP-1 RAs) lower the risk of ...

New data and analyses presented at the American Diabetes Association’s annual meeting highlight the priorities for the next ...

Women and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein intake may help prevent muscle loss in these patients, according to a small ...

Though long-term prospects appear sound, near-term earnings visibility remains limited for Dr. Reddy's Labs, Cipla, and Lupin ...

New study published by Truveta and Harvard Medical School A groundbreaking study published today in Pediatrics Open Science ...

Morgan Stanley sees earnings growth in the pharma sector moderating in FY25–27, though robust balance sheets could support ...

Scientists have gene-hacked mice to produce their own Ozempic-like drugs, paving a path for humans to do so themselves one ...

Glenmark’s progress with a cancer treatment shows the potential of Indian pharma to move from generics to drug discovery.